Along with Houston-based real estate developer Ancorian, Common Desk is headed for Houston. Courtesy of Common Desk

Houston will soon be home to another large coworking space. Common Desk, a Texas company, has announced plans for a Houston location in East Downtown — selected for its culture and opportunity.

The Dallas-born concept specializes in coworking in hospitality and has joined forces with Houston-based Ancorian, a real estate development company, for the project. Expected to open in summer 2020, Common Desk will occupy 25,000 square feet of a 42,000-square-foot warehouse redevelopment known as "The Block." The facility will also have an outpost of Dallas-based Bishop Cider.

"EaDo reminds us of Deep Ellum, which was the first location we ever opened in Dallas in 2012," says Nick Clark, founder and CEO of Common Desk, in a news release. "It has the cultural authenticity and significance that we as a brand love to build a foundation from, offering the diverse variety of concepts and convenience you want from a submarket, without the congestion and parking difficulties you might find in a central business district. We're excited to bring some of our soulful vibes and southern hospitality to Eado."

Houston's East Downtown Common Desk will occupy 25,000 square feet of a 42,000-square-foot warehouse redevelopment known as "The Block." Courtesy of Common Desk

Common Desk, which got its start in 2012, now has eight locations in the Dallas-Fort Worth area and three in in Austin, and its Houston members will eventually have access to these other locations. A common theme in the companies concepts is bridging the gap between coworking and dining and hospitality concepts. Fiction Coffee, Common Desk's coffee bar concept, is expected to open alongside the coworking space.

"Houston isn't just another market for us; it's a city we love, and we expect our approach to service and design to resonate well with Houstonians," says Dawson Williams, head of real estate at Common Desk, in the release. "We plan to go deep in Houston just as we have in Dallas, and our goal is to become the go-to coworking brand in the market."

Ancorian has previously worked on the East Village in the East Downtown area, which include concepts like Indianola, Truck Yard, F45 Fitness, Koffeteria, Rodeo Goat, and True Anomaly Brewing.

"We are heavily invested in East Downtown Houston, and we felt that our latest development 'The Block' was a perfect location for a coworking concept," says Michael Sperandio, founding partner of Ancorian. "We work very hard to choose tenants that fit each specific development we create. After meeting Nick Clark and Dawson Williams of Common Desk, we felt like they were the best operators in the coworking space industry."

Houston's Common Desk location will have a warehouse feel and is expected to feature various amenities and member perks, including:

  • Fitness and wellness center concept, complete with towels and shower facilities
  • Outdoor patio and terrarium
  • Multi-level seating
  • Wet bar and shared kitchen
  • Skylights that will bring in natural lighting
  • Event space
  • Murals and local art

"This group puts together all the necessary elements to draw people into their workspaces," Sperandio continues. "They focus on great design, thoughtful and functional space layout, and they have created an energetic and comfortable environment that attracts new members and keeps existing members loyal to the Common Desk brand. We feel that Common Desk's vision for an experiential workspace will make this one of the best locations to work in the entire city."

Houston's Common Desk members will have access to other Texas locations. Courtesy of Common Desk

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

New UH survey reveals concerns over AI data center growth in Houston

data findings

A new report out of the University of Houston shows that area residents remain wary of the long-term effects of operating data centers.

The recent survey from the University of Houston’s latest SPACE City Panel, conducted by the Center for Public Policy at the Hobby School of Public Affairs, shows that while 85 percent of Houston-area residents use AI, nearly 63 percent oppose the construction of AI data centers within 1 mile of their homes.

Respondents’ concerns centered around data centers’ high energy demand and the area’s power grid reliability. According to the survey, 32 percent of residents who oppose local data center projects would be more likely to support the centers if they relied on renewable energy over fossil fuels.

“Respondents understand that AI can bring economic and educational benefits, but they are also concerned about the physical infrastructure needed to fuel AI, especially data centers,” Soran Mohtadi, post-doctoral fellow at the Hobby School and a researcher on the report, said in a news release. “This physical infrastructure demands more electricity and water, leading to environmental impacts.”

Experts estimate that 6.5 gigawatts of data center capacity will be added to the Texas grid by 2030. And Houston’s data center capacity is predicted to more than double by 2028.

The Electric Reliability Council of Texas also projects electricity demand could reach 218 gigawatts by 2031, which would be more than double the record peak set in August 2023. Data centers are expected to account for 86 gigawatts of that new demand.

Survey respondents also said they are concerned about the state's future water supply, given the large amounts of water that data centers need to stay cool.

In terms of who’s responsible for that issue, 57.6 percent of respondents said they put the onus on Texas lawmakers, while 31.5 percent say tech companies should be responsible.

Additionally, more than 75 percent of respondents believed that data center developers and technology companies—not residents—should bear the cost of infrastructure upgrades to support data centers.

“Every decision legislators make has implications on residents’ everyday lives and local infrastructure now and in the future,” Maria P. Perez Arguelles, lead researcher on the report and research assistant professor at the Hobby School, added in the news release. “This issue is going to become more important in years to come, so this is just the beginning.”

Read the full report here.

Houston-born Cemvita makes breakthrough in sustainable fuel production

clean fuels

Houston-based biotech company Cemvita announced that it recently reached a critical milestone in the development of its FermOil product, which can be used to create Sustainable Aviation Fuel (SAF) and other renewable fuels at industrial scale.

The company shared in a news release that it completed a 75,000-liter industrial fermentation run at Belgium's Bio Base Europe Pilot Plant.

The campaign achieved target technical metrics for the production of FermOil, Cemvita’s renewable natural oil (RNO). FermOil is produced from industrial crude glycerin, an industrial byproduct, as opposed to traditional sugar-based feedstocks used in many bio-oil fermentation processes. It's designed to be a drop-in feedstock for creating SAFs.

Cemvita had previously advanced its FermOil production process through multiple scale-up stages before successfully reaching the 75,000-liter demonstration campaign, according to the company.

“This is not just a fermentation milestone,” Moji Karimi, CEO at Cemvita, said in the release. “It is a blueprint for how existing industrial infrastructure can evolve into circular bioeconomy infrastructure. Every biodiesel plant generating crude glycerin is a potential platform for renewable natural oil production.”

The milestone also supports the deployment of Cemvita’s industrial biomanufacturing platform, FermWorks, which integrates with existing energy and industrial infrastructure to turn waste carbon streams into SAFs and other materials. According to the release, Cemvita plans to move forward with commercial deployment discussions with partners in Brazil, Europe and in the UK. Cemvita already has a partnership with the Brazilian sustainable research institution REMA.

“We are proud to support innovative companies like Cemvita in scaling breakthrough industrial biotechnology solutions,” Hendrik Waegeman, head of business operations at Bio Base Europe Pilot Plant, added in the release. “Successfully operating at the 75,000-liter scale using a feedstock such as crude glycerin highlights both the maturity of the technology and the quality of the scale-up execution achieved by the Cemvita team.”

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Eli Lilly scoops up Houston biotech startup in $300 million deal

big pharma deal

Pharmaceutical giant Eli Lilly has acquired Houston biotech startup CrossBridge Bio, which develops antibody-drug conjugates for cancer, in a deal worth up to $300 million. The deal was celebrated by TMC Venture Fund and the University of Texas Health Science Center at Houston last week.

CrossBridge, founded in 2023, is developing ADCs based on research by Kyoji Tsuchikama and Zhiqiang An, both of UT Health Houston. Tsuchikama is an associate professor of medicinal chemistry and a globally recognized ADC pioneer, and An is a professor of molecular science and vice president of drug discovery.

Antibody-drug conjugates (ADCs) are a potent combination of targeted therapy and chemotherapy that kills cancer cells while saving healthy tissue.

Clinical trials for CrossBridge’s primary ADC candidate, CBB-120, are expected to start this year, pending approval from the U.S. Food and Drug Administration (FDA).

“I’m proud of how well our team has executed and advanced our platform in such a short time since the company’s founding,” Michael Torres, co-founder and CEO of CrossBridge, said in a news release. “By becoming a part of Lilly, a leader in patient-focused therapeutic development, we are well-positioned to further accelerate the clinical potential of this approach.”

Under the Lilly deal, CrossBridge shareholders were expected to receive an upfront payment along with a follow-up payment based on the achievement of certain milestones.

In 2024, CrossBridge closed a $10 million seed round. Among the investors in CrossBridge are the Texas Medical Center Venture Fund, CE-Ventures, Alexandria Venture Investments, Portal Innovations, Linden Lake Labs, and the Cancer Prevention and Research Institute of Texas (CPRIT). It was formed in TMC Innovation’s Accelerator for Cancer Therapeutics program."Built within the TMC ecosystem, CrossBridge Bio grew with the support, funding, and resources that helped shape its trajectory. TMC led the company's early financing and watched it evolve from its earliest days to its acquisition by Eli Lilly," William McKeon, president and CEO of the Texas Medical Center, shared in a LinkedIn post. "[This is a] strong reminder that breakthrough science and the right early backing can change what’s possible."